Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Butt

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
JMIR Formative Research|July 15, 2025
Reducing Methamphetamine Use in Aboriginal and Torres Strait Islander Communities With the "We Can Do This" Web App: Qualitative Evaluation of Acceptability and FeasibilityLeda Sivak, Rachel Reilly, Shani Crumpen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2024
Common infections and neuroimaging markers of dementia in three UK cohort studiesRebecca E Green, Carole H Sudre, Charlotte Warren-Gash, et al.
Clinical & Translational Immunology|April 20, 2026
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosisJens Ingvarsson, Viktor Grut, Martin Biström, et al.
JMIR Research Protocols|May 1, 2021
A Web-Based Therapeutic Program (We Can Do This) for Reducing Methamphetamine Use and Increasing Help-Seeking Among Aboriginal and Torres Strait Islander People: Protocol for a Randomized Wait-List Controlled TrialRachel Reilly, Rebecca McKetin, Handan Wand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2018
Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin LymphomaGordana Halec, Tim Waterboer, Nicole Brenner, et al.
Journal of Medical Internet Research|March 7, 2025
Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled TrialRachel Reilly, Rebecca McKetin, Federica Barzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and PepsinogenJohn D Murphy, Andrew F Olshan, Feng-Chang Lin, et al.
BMC Infectious Diseases|June 4, 2024
COVID-19 and long-term impact on symptoms and Health-Related Quality of Life in Costa Rica: the RESPIRA cohort studyCristina Barboza-Solis, Romain Fantin, Allan Hildesheim, et al.
Helicobacter|February 9, 2024
Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCOGwen Murphy, Neal D Freedman, Christian C Abnet, et al.
Journal of Public Health (Oxford, England)|May 16, 2025
A population-based case-control study of COVID-19: methodological considerations on the role of testing biasRomain Fantin, Carolina Porras, Amada Aparicio, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
JMIR Formative Research|July 15, 2025
Reducing Methamphetamine Use in Aboriginal and Torres Strait Islander Communities With the "We Can Do This" Web App: Qualitative Evaluation of Acceptability and FeasibilityLeda Sivak, Rachel Reilly, Shani Crumpen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2024
Common infections and neuroimaging markers of dementia in three UK cohort studiesRebecca E Green, Carole H Sudre, Charlotte Warren-Gash, et al.
Clinical & Translational Immunology|April 20, 2026
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosisJens Ingvarsson, Viktor Grut, Martin Biström, et al.
JMIR Research Protocols|May 1, 2021
A Web-Based Therapeutic Program (We Can Do This) for Reducing Methamphetamine Use and Increasing Help-Seeking Among Aboriginal and Torres Strait Islander People: Protocol for a Randomized Wait-List Controlled TrialRachel Reilly, Rebecca McKetin, Handan Wand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2018
Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin LymphomaGordana Halec, Tim Waterboer, Nicole Brenner, et al.
Journal of Medical Internet Research|March 7, 2025
Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled TrialRachel Reilly, Rebecca McKetin, Federica Barzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and PepsinogenJohn D Murphy, Andrew F Olshan, Feng-Chang Lin, et al.
BMC Infectious Diseases|June 4, 2024
COVID-19 and long-term impact on symptoms and Health-Related Quality of Life in Costa Rica: the RESPIRA cohort studyCristina Barboza-Solis, Romain Fantin, Allan Hildesheim, et al.
Helicobacter|February 9, 2024
Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCOGwen Murphy, Neal D Freedman, Christian C Abnet, et al.
Journal of Public Health (Oxford, England)|May 16, 2025
A population-based case-control study of COVID-19: methodological considerations on the role of testing biasRomain Fantin, Carolina Porras, Amada Aparicio, et al.
Pageof 13